In addition to NCC EMT, our work may also help to inform the phenotypic changes and corresponding gene regulatory control of EMP in other developmental EMT events as well as pathological conditions such as tissue fibrosis and cancer progression. This evidence concerns the gene SLC12A3 and cancer.